Ambit

Ambit

  • Founded in 2000
  • 51-200 Employees

Careers at Ambit


About Ambit

Ambit is a biopharmaceutical company dedicated to the discovery, development, and commercialization of drugs designed to meet unmet medical needs in oncology, autoimmune, and inflammatory diseases. The company focuses on inhibiting kinases, which play a crucial role in these diseases, and has developed a pipeline of kinase inhibitors. Ambit's lead drug candidate, quizartinib, is an orally administered FLT3 kinase inhibitor aimed at treating acute myeloid leukemia (AML). With a strong emphasis on internally discovered programs, Ambit leverages its expertise in kinase inhibition to create a sustainable pipeline of small molecule drugs.